Rapid Micro Biosystems, Inc. RPID · SEC Filings

171

Rapid Micro Biosystems, Inc. operates as a life sciences technology firm, supplying advanced solutio...

Price0.73

Market Cap37.1 M

Float35.57 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 15, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 12, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 7, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 9, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Aug 7, 2026

8-K

Rapid Micro Biosystems, Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 28, 2026

8-K

Rapid Micro Biosystems Announces Underwritten Offering and Concurrent Registered Direct Offering

May 19, 2026

8-K

Rapid Micro Biosystems Reports First Quarter 2026 Financial Results

May 13, 2026

8-K

Rapid Micro Biosystems Announces Departure of COO John Wilson

Mar 27, 2026

8-K

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Mar 12, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

May 19, 2026

424B5

REGISTERED OFFERING

May 19, 2026

424B3

UPDATED | ATM | Offering amount: $10,000,000.00 | Float: 33,409,105

Dec 28, 2023

424B4

OFFERING | Shares amount: 7,920,000 | Share price: $20.00 | Offering amount: $158,400,000.00

Jul 16, 2021

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 12, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Feb 28, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 1, 2024

S-3

SHELF | ATM | Offering amount: $200,000,000.00 | Float: 33,000,000 EFFECTIVE

Dec 15, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 4, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Mar 14, 2023

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 8, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 8, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 8, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 8, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 9, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 9, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

ARMISTICE CAPITAL, LLC (Filed by)

Aug 14, 2026

SCHEDULE 13G/A

Bain Capital Life Sciences Fund, L.P. (Filed by)

Aug 14, 2026

4

Kollender Richard S (Reporting)

Jul 24, 2026

4

Spignesi Robert G. Jr. (Reporting)

Jul 24, 2026

144

Form 144 - Report of proposed sale of securities

Jul 8, 2026

144

Form 144 - Report of proposed sale of securities

Jul 1, 2026

Other

TYPE

HEADLINE

FILED AT

SD

Form SD - Specialized disclosure report

May 29, 2026

SD

Form SD - Specialized disclosure report

May 28, 2025

SD

Form SD - Specialized disclosure report

May 29, 2024

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 27, 2023

CORRESP

Form CORRESP - Correspondence

Dec 21, 2023

LETTER

Form UPLOAD - SEC-generated letter

Dec 21, 2023